 |
Calliditas Therapeutics
Last updated: July 29, 2024
Renee Aguiar-Lucander, CEO
Sweden | Funding: $210.4M (+)
Website: https://www.calliditas.se
Calliditas Therapeutics, a specialty pharmaceutical company that develops pharmaceutical products in fields of unmet medical need. Its products include Nefecon, a treatment for IgA nephropathy and Busulipo, an alternative for myeloablation prior to bone marrow transplantation.
Website: https://www.calliditas.se
Calliditas Therapeutics, a specialty pharmaceutical company that develops pharmaceutical products in fields of unmet medical need. Its products include Nefecon, a treatment for IgA nephropathy and Busulipo, an alternative for myeloablation prior to bone marrow transplantation.
